Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer and Chief Business Officer
BOSTON,MA / ACCESSWIRE / Oct 6,2021 /Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a medical-phase biotechnology company advancing novel biotherapeutics via its proprietary Anticalin® engineering system for respiratory...